Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental
glomerulosclerosis. Nat Genet 2000;24:251-6.
Focal and segmental
glomerulosclerosis: definition and relevance of a partial remission.
These patients were on the tenofovir based regimen, the biopsy revealed interstitial nephritis with
glomerulosclerosis which could be due to TDF.
Wei et al., "Rituximab targets podocytes in recurrent focal segmental
glomerulosclerosis," Science Translational Medicine, vol.
Kalluri, "Renal fibrosis and
glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors," Diabetes, vol.
Vincenti, "Recurrent focal
glomerulosclerosis: natural history and response to therapy," American Journal of Medicine, vol.
Interestingly, this patient showed typical features of hepatic
glomerulosclerosis, including chronic sclerotic and fibrotic changes, upon histological examination.
It showed that in 100 patients who developed renal disease whilst on anti-VEGF treatment, the main histology associated with TKIs was minimal change disease and/or collapsing-like focal segmental
glomerulosclerosis (MCN/cFSGS), a FSGC variant which is considered a separate entity to FSGS.
Abbreviations EPS: Encapsulating peritoneal sclerosis PD: Peritoneal dialysis ESRD: End-stage renal disease HD: Hemodialysis LOA: Lysis of adhesions OSH: Outside hospital SBO: Small bowel obstruction TPN: Total parenteral nutrition NGT: Nasogastric tube FSGS: Focal segmental
glomerulosclerosis POD: Postoperative day.
Effect of various histological changes on graft function at 1 month Histological changes if Number of Effect on graft function cortical biopsy patients (out of 84) Normal histology 48 (58%) No effect
Glomerulosclerosis 21 (25%) No effect Interstitial fibrosis 11 (13%) Delayed graft function: 4 Acute tubular necrosis 4 (5%) Acute rejection: 2 Delayed graft function: 2 Focal tubal atrophy 4 (5%) No effect Table 2.
Canada-based Aurinia Pharmaceuticals is planning to expand its voclosoprin renal franchise to include focal segmental
glomerulosclerosis (FSGS) and minimal change disease (MCD), it was reported on Monday.
This might give the team insight into how to counter the effects of congenital gene mutations that can cause
glomerulosclerosis, another common cause of kidney failure.